GW Pharma (GWPH) Posts Near-Breakeven Q4 Profit

GW Pharma (NASDAQ: GWPH) reported Q4 EPS of $0.00, $0.69 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $12.03 million versus the consensus estimate of $14.6 million.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Reaction roundup: Experts, analysts weigh in on September jobs report
• Onto Innovation gains on bullish RBC initiation citing advanced packaging growth